Anne d’Andon joined CEMKA as Medical Director, providing medical expertise, strategic advice and technical support to the company’s various business areas.
As a doctor, she worked at INSERM on the genetics of Hypertension and then devoted herself to the development of health products and the management of clinical research, particularly in the field of rare diseases. At the same time, she continued her training and obtained CESAM, a master diploma in cardiovascular pharmacology and certificates in human genetics and molecular biology.
Anne d’Andon has successively managed the research departments of two patient associations, the association Overcome the mucoviscidosis and the French association against Myopathies – Téléthon, thus ensuring the proper allocation of funds in research aimed at improving the health of patients with rare diseases. She was Deputy Medical Director at Genzyme where she participated in the development of advanced therapy drugs. She then headed the drug evaluation department of the High Authority of Health for 10 years, adding to her experience national and international expertise in technology evaluation, in the city or in the hospital, as well as in the entire life cycle of the drug.
She is involved in numerous university training courses, conferences, congresses on access to the drug market, real life data and innovative email@example.com